Secondary
Proteostasis Therapeutics
: Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis (CF) and other diseases caused by dysfunctional protein processing.
Symbol
PTI
Last Closing Price
$5.47
Effective Date
December 14, 2017
Underwriters
Leerink Partners, RBC Capital Markets
To view the prospectus for Proteostasis Therapeutics, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277